Gemini Therapeutics, Inc. (GMTX) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Gemini Therapeutics, Inc. (GMTX:NASDAQ), powered by AI.
- Current Price
- $67.99
- P/E Ratio
- -7.6
- Market Cap
- 545M
- Sector
- Unknown
What is the Gemini Therapeutics, Inc. stock price forecast?
Gemini Therapeutics, Inc. is currently trading at $67.99. View real-time AI analysis on Alpha Lenz.
What is Gemini Therapeutics, Inc. insider trading activity?
View the latest insider trading data for Gemini Therapeutics, Inc. on Alpha Lenz.
What is Gemini Therapeutics, Inc.'s P/E ratio?
Gemini Therapeutics, Inc.'s P/E ratio is -7.6.
Gemini Therapeutics, Inc.
NASDAQ · GMTX“Gemini Therapeutics, Inc. trades at a P/E of -7.6 (undervalued) with strong ROE of 196.3%.”
Ask for details →Company Overview
Company Statistics
FY 2021Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Gemini Therapeutics, Inc. trades at a P/E of -7.6 (undervalued) with strong ROE of 196.3%.”
Ask for details →Frequently Asked Questions
Gemini Therapeutics, Inc. (ticker: GMTX) is a company listed on NASDAQ in the Unknown sector (Unknown). Market cap is $545M.
The current price is $67.99 with a P/E ratio of -7.58x and P/B of -2.95x.
ROE is 196.28%.